In vitro evaluation of the dissolution behaviour of itraconazole in bio-relevant media

International Journal of Pharmaceutics

Volumn 366, Issue 1-2, 2009, Pages 117-123

  Ghazal, Heba S ^a   Dyas, A Mark ^b   Ford, James L ^a   Hutcheon, Gillian A ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b LifeCycle Pharma   (Denmark)

Author keywords

Bio relevant dissolution media; Dissolution; Intrinsic dissolution rate; Itraconazole; Solubility

Indexed keywords

ALANINE; ALBUMIN; AMINO ACID DERIVATIVE; ASPARTIC ACID; CARBOHYDRATE; CASEIN; GELATIN; GLUCOSE; GLUTEN; GLYCINE; ITRACONAZOLE; LACTOSE; LYSINE; PHOSPHATIDYLCHOLINE; STARCH; TAUROCHOLIC ACID;

ARTICLE; DRUG SOLUBILITY; EVALUATION; FAT CONTENT; IN VITRO STUDY; MEAL; MILK; PRIORITY JOURNAL; SIMULATION; STOMACH JUICE;

AMINO ACIDS; ANIMALS; ANTIFUNGAL AGENTS; BILE; BIOLOGICAL AVAILABILITY; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; FOOD-DRUG INTERACTIONS; GASTRIC JUICE; INTESTINAL SECRETIONS; ITRACONAZOLE; MILK; SOLUBILITY;

EID: 57849154793     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.09.003     Document Type: Article

References (37)

1. Aburub A., Risley D.S., and Mishra D. A critical evaluation of fasted state simulating gastric fluid (FaSSGF) that contains sodium lauryl sulfate and proposal of a modified recipe. Int. J. Pharm. 347 (2008) 16-22
2. Acarturk F., Kislal O., and Celebi N. The effect of some natural polymers on the solubility and dissolution characteristics of nifedipine. Int. J. Pharm. 85 (1992) 1-6
3. Aiache J.M., Aoyagi N., Blume H., Dressman J., Friedel H.B., and Grady I.T. FIP guidelines for dissolution testing of solid oral products. Dissolution Technol. 4 (1997) 5-13
4. Amidon G.L., Lennernaes H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995) 413-420
5. Ashby L.J., Beezer A.E., and Buckton G. In vitro dissolution testing of oral controlled release preparations in the presence of artificial foodstuffs. I. Exploration of alternative methodology: microcalorimetry. Int. J. Pharm. 51 (1989) 245-251
6. Barone J.A., Koh J.G., Bierman R.H., and Colaizzi J.L. Food Interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrob. Agents Chemother. 37 (1993) 778-784
7. Bradford M.M. A rapid and sensitive for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
8. CDER/FDA, 1997. Guidance for Industry, Dissolution Testing of Immediate Release Solid Oral Dosage Forms, August 1997.
9. Dressman J.B., and Reppas C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 11 Suppl. 2 (2000) 73-80
10. Dressman J.B., Amidon G.L., Reppas C., and Shah V.P. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 15 (1998) 11-22
11. Galia E., Horton J., and Dressman J.B. Albendazole generics-a comparative in vitro study. Pharm. Res. 16 (1999) 1871-1875
12. Galia E., Nicolaides E., Hoerter D., Loebenberg R., Reppas C., and Dressman J.B. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm. Res. 15 (1998) 698-705
13. Heykants J., Van Peer A., Van de Velde V., Van Rooy P., Meuldermans W., Lavrijson K., Woestenborghs R., Van Cutsem J., and Gauwenbergh G. The clinical pharmacokinetics of itraconazole: an overview. Mycoses 32 Suppl. 1 (1989) 67-87
14. Imai T., Saito Y., Matsumoto H., Satoh T., and Otagiri M. Influence of egg albumin on dissolution of several drugs. Int. J. Pharm. 53 (1989) 7-12
15. Kallinteri P., and Antimisiaris S. Solubility of drugs in the presence of gelatin: effect of drug lipophilicity and degree of ionization. Int. J. Pharm. 221 (2001) 219-226
16. Klein S., Butler J., Hempenstall J.M., Reppas C., and Dressman J.B. Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts. J. Pharm. Pharmacol. 56 (2004) 605-610
17. Lange D., Pavao J.H., Wu J., and Klausner M. Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers. J. Clin. Pharmacol. 37 (1997) 535-540
18. Levy G. Effect of certain tablet formulation factors on dissolution rate of the active ingredient. I. Importance of using appropriate agitation intensities for in vitro dissolution rate measurements to reflect in vivo conditions. J. Pharm. Sci. 52 (1963) 1039-1046
19. Lohitnavy M., Lohitnavy O., Thangkeattiyanon O., and Srichai W. Reduced oral itraconazole bioavailability by antacid suspension. J. Clin. Pharm. Therapeut. 30 (2005) 201-206
20. Macheras P., and Reppas C. Studies on freeze-dried drug-milk formulations. II. Effect of regenerated fluid volume on nitrofurantoin bioavailability. J. Pharm. Sci. 75 (1986) 1145-1150
21. Macheras P., and Reppas C. Dissolution and in vitro permeation behaviours of dicumarol nitrofurantoin and sulfamethizole in the presence of protein. Int. J. Pharm. 37 (1987) 103-112
22. Macheras P., Koupparis M., and Antimisiaris S. An in vitro model for exploring CR theophylline-milk fat interactions. Int. J. Pharm. 54 (1989) 123-130
23. Macheras P., Koupparis M., and Apostolelli E. Dissolution of 4 controlled-release theophylline formulations in milk. Int. J. Pharm. 36 (1987) 73-79
24. Macheras P., Koupparis M., and Tsaprounis C. Drug dissolution studies in milk using the automated flow injection serial dynamic dialysis technique. Int. J. Pharm. 33 (1986) 125-136
25. Marques M. Dissolution media simulating fasted and fed states. Dissolution Technol. 11 (2004) 16
26. Naylor L.J., Bakatselou V., and Dressman J.B. Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Pharm. Res. 10 (1993) 865-870
27. Nicolaides E., Galia E., Efthymiopoulos C., Dressman J.B., and Reppas C. Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data. Pharm. Res. 16 (1999) 1876-1882
28. Pedersen B.L., Brøndsted H., Lennernäs H., Christensen F.N., Müllertz A., and Kristensen H.G. Dissolution of hydrocortisone in human and simulated intestinal fluids. Pharm. Res. 17 (2000) 183-189
29. Peeters J., Neeskens P., Tollenaere J.P., Van Remoortere P., and Brewster M.E. Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4 and 7. J. Pharm. Sci. 91 (2002) 1414-1422
30. Persson E.M., Gustafsson A.S., Carlsson A.S., Nilsson R.G., Knutson L., Forsell P., Hanisch G., Lennernas H., and Abrahamsson B. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm. Res. 22 (2005) 2141-2151
31. Sunesen V.H., Pedersen B.L., Kristensen H.G., and Mullertz A. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. Eur. J. Pharm. Sci. 24 (2005) 305-313
32. Van Peer A., Woestenborghs R., Heykants J., Gasparini R., and Gauwenbergh G. The Effects of food and dose on the oral systemic availability of itraconazole in healthy subjects. Eur. J. Clin. Pharmacol. 36 (1989) 423-426
33. Vertzoni M., Dressman J., Butler J., Hempenstall J., and Reppas C. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. Eur. J. Pharm. Biopharm. 60 (2005) 413-417
34. Vertzoni M., Fotki N., Kostewicz E., Stippler E., Leuner C., Nicolaides E., Dressman J., and Reppas C. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects. J. Pharm. Pharmacol. 56 (2004) 453-462
35. Viegas T.X., Curatella R.U., Van Winkle L.L., and Brinker G. Measurement of intrinsic drug dissolution rates using two types of apparatus. Pharmaceut. Technol. 25 (2001) 44-53
36. US Pharmacopeia 30, 2007. US Pharmacopeial Convention, Rockville, MD.
37. Zimmermann T., Yeates R.A., Laufen H., Pfaff G., and Wildfeuer A. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole. Eur. J. Clin. Pharmacol. 46 (1994) 147-150